118 related articles for article (PubMed ID: 32772271)
1. BTB domain-containing 7 predicts low recurrence and suppresses tumor progression by deactivating Notch1 signaling in breast cancer.
Chen J; Lai YH; Ooi S; Song Y; Li L; Liu TY
Breast Cancer Res Treat; 2020 Nov; 184(2):287-300. PubMed ID: 32772271
[TBL] [Abstract][Full Text] [Related]
2. BTB/POZ domain-containing protein 7 is inversely associated with fibronectin expression in salivary adenoid cystic carcinoma.
Liu Y; Song J; Zhang J; Yang L; Liu Z; Wang X
Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 May; 125(5):468-477. PubMed ID: 29366608
[TBL] [Abstract][Full Text] [Related]
3. BTBD7 silencing inhibited epithelial- mesenchymal transition (EMT) via regulating Slug expression in human salivary adenoid cystic carcinoma.
Yang L; Wang T; Zhang J; Wang X
Cancer Biomark; 2017 Dec; 20(4):461-468. PubMed ID: 28946551
[TBL] [Abstract][Full Text] [Related]
4. High BTBD7 expression positive is correlated with SLUG-predicted poor prognosis in hormone receptor-negative breast cancer.
Li ZX; Huang ZN; Luo H; Yang XB; Wang YL; Chen JX; Ma XK; Xu F; Wang TT; Lin L
Ann Transl Med; 2021 Aug; 9(15):1252. PubMed ID: 34532389
[TBL] [Abstract][Full Text] [Related]
5. Notch1 signaling regulates the epithelial-mesenchymal transition and invasion of breast cancer in a Slug-dependent manner.
Shao S; Zhao X; Zhang X; Luo M; Zuo X; Huang S; Wang Y; Gu S; Zhao X
Mol Cancer; 2015 Feb; 14(1):28. PubMed ID: 25645291
[TBL] [Abstract][Full Text] [Related]
6. BTB/POZ domain-containing protein 7: epithelial-mesenchymal transition promoter and prognostic biomarker of hepatocellular carcinoma.
Tao YM; Huang JL; Zeng S; Zhang S; Fan XG; Wang ZM; Yang HX; Yuan XH; Wang P; Wu F; Luo J; Zeng DY; Shen H
Hepatology; 2013 Jun; 57(6):2326-37. PubMed ID: 23325674
[TBL] [Abstract][Full Text] [Related]
7. Expression of BTBD7 in primary salivary adenoid cystic carcinoma and correlation with Slug and prognosis.
Yang L; Wang T; Zhang J; Liu Z; Wang X
Cancer Biomark; 2016 Jun; 17(2):179-85. PubMed ID: 27540976
[TBL] [Abstract][Full Text] [Related]
8. The Role of BTBD7 in Normal Development and Tumor Progression.
Liu Y; Song J; Gu J; Xu S; Wang X; Liu Y
Technol Cancer Res Treat; 2023; 22():15330338231167732. PubMed ID: 37050886
[TBL] [Abstract][Full Text] [Related]
9. Extracellular Vesicles Carrying miR-887-3p Promote Breast Cancer Cell Drug Resistance by Targeting BTBD7 and Activating the Notch1/Hes1 Signaling Pathway.
Wang B; Wang Y; Wang X; Gu J; Wu W; Wu H; Wang Q; Zhou D
Dis Markers; 2022; 2022():5762686. PubMed ID: 35655918
[TBL] [Abstract][Full Text] [Related]
10. Effects of Btbd7 knockdown on the proliferation of human dental pulp cells and expression of Dspp.
Bao Q; Zhang J; Wang XX
Int J Clin Exp Pathol; 2018; 11(3):1460-1465. PubMed ID: 31938244
[No Abstract] [Full Text] [Related]
11. Btbd7 contributes to reduced E-cadherin expression and predicts poor prognosis in non-small cell lung cancer.
Fan C; Miao Y; Zhang X; Liu D; Jiang G; Lin X; Han Q; Luan L; Xu Z; Wang E
BMC Cancer; 2014 Sep; 14():704. PubMed ID: 25253020
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of SNHG1 suppresses cell proliferation and invasion by regulating Notch signaling pathway in esophageal squamous cell cancer.
Zhang Y; Jin X; Wang Z; Zhang X; Liu S; Liu G
Cancer Biomark; 2017 Dec; 21(1):89-96. PubMed ID: 29081407
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA NALT1-induced gastric cancer invasion and metastasis
Piao HY; Guo S; Wang Y; Zhang J
World J Gastroenterol; 2019 Nov; 25(44):6508-6526. PubMed ID: 31802831
[TBL] [Abstract][Full Text] [Related]
14. [Suppression of hepatocellular carcinoma invasion and metastasis by Rho-kinase inhibitor Fasudil through inhibition of BTBD7-ROCK2 signaling pathway].
Hu K; Wang Z; Tao Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2014 Dec; 39(12):1221-7. PubMed ID: 25544168
[TBL] [Abstract][Full Text] [Related]
15. The Prognostic Value of Cancer Stem Cell Markers (Notch1, ALDH1, and CD44) in Primary Colorectal Carcinoma.
Mohamed SY; Kaf RM; Ahmed MM; Elwan A; Ashour HR; Ibrahim A
J Gastrointest Cancer; 2019 Dec; 50(4):824-837. PubMed ID: 30136202
[TBL] [Abstract][Full Text] [Related]
16. NDR1 increases NOTCH1 signaling activity by impairing Fbw7 mediated NICD degradation to enhance breast cancer stem cell properties.
Wang LL; Wan XY; Liu CQ; Zheng FM
Mol Med; 2022 May; 28(1):49. PubMed ID: 35508987
[TBL] [Abstract][Full Text] [Related]
17. Elevated expression of syntenin in breast cancer is correlated with lymph node metastasis and poor patient survival.
Yang Y; Hong Q; Shi P; Liu Z; Luo J; Shao Z
Breast Cancer Res; 2013 Jun; 15(3):R50. PubMed ID: 23786877
[TBL] [Abstract][Full Text] [Related]
18. Association of BTBD7 with Metastasis and Poor Prognosis in Non-Small-Cell Lung Cancer Patients.
Luo FY; Liu ZH; Hu QH; Lin GQ; Tang CE; Zhang WX; Zhuang W
J Cancer; 2015; 6(5):477-81. PubMed ID: 25874012
[TBL] [Abstract][Full Text] [Related]
19. BTB/POZ zinc finger protein ZBTB16 inhibits breast cancer proliferation and metastasis through upregulating ZBTB28 and antagonizing BCL6/ZBTB27.
He J; Wu M; Xiong L; Gong Y; Yu R; Peng W; Li L; Li L; Tian S; Wang Y; Tao Q; Xiang T
Clin Epigenetics; 2020 Jun; 12(1):82. PubMed ID: 32517789
[TBL] [Abstract][Full Text] [Related]
20. BTBD7 accelerates the epithelial-mesenchymal transition, proliferation and invasion of prostate cancer cells.
Chen B; Liu C; Bai G; Zhu Y; Xu H
J BUON; 2021; 26(5):2111-2116. PubMed ID: 34761624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]